Literature DB >> 15285978

Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder.

Jonathan D Huppert1, Luke T Schultz, Edna B Foa, David H Barlow, Jonathan R T Davidson, Jack M Gorman, M Katherine Shear, H Blair Simpson, Scott W Woods.   

Abstract

OBJECTIVE: Placebo effects in treatment of three anxiety disorders were compared.
METHOD: Treatment response and patients' treatment expectancy were examined by using data from 70 patients with obsessive-compulsive disorder, social phobia, or panic disorder who received placebo in three randomized, controlled trials comparing cognitive behavior therapy, medication, and their combination to placebo.
RESULTS: Patients with obsessive-compulsive disorder were less likely to respond to placebo than patients with generalized social phobia or panic disorder. Differential expectancy did not account for these findings.
CONCLUSIONS: Further examination of the placebo effect across the anxiety disorders may elucidate maintenance mechanisms of these disorders and have implications for development of more effective treatments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15285978     DOI: 10.1176/appi.ajp.161.8.1485

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  16 in total

1.  Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement?

Authors:  Michael G Wheaton; David Rosenfield; Edna B Foa; H Blair Simpson
Journal:  J Consult Clin Psychol       Date:  2015-05-25

2.  The effect of social anxiety on urge and craving among smokers with and without anxiety disorders.

Authors:  Nathan A Kimbrel; Sandra B Morissette; Suzy B Gulliver; Kirsten J Langdon; Michael J Zvolensky
Journal:  Drug Alcohol Depend       Date:  2013-11-13       Impact factor: 4.492

Review 3.  Meta-Analysis of Placebo Response in Adult Antidepressant Trials.

Authors:  Fenghua Li; Madeeha Nasir; Baris Olten; Michael H Bloch
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

4.  Patient utilization of cognitive-behavioral therapy for OCD.

Authors:  Maria C Mancebo; Jane L Eisen; Nicholas J Sibrava; Ingrid R Dyck; Steven A Rasmussen
Journal:  Behav Ther       Date:  2011-03-05

Review 5.  Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review.

Authors:  Shaheen E Lakhan; Karen F Vieira
Journal:  Nutr J       Date:  2010-10-07       Impact factor: 3.271

6.  Treatment of obsessive-compulsive disorder complicated by comorbid eating disorders.

Authors:  H Blair Simpson; Chad T Wetterneck; Shawn P Cahill; Joanna E Steinglass; Martin E Franklin; Rachel C Leonard; Theodore E Weltzin; Bradley C Riemann
Journal:  Cogn Behav Ther       Date:  2013-01-15

Review 7.  Mechanisms of the placebo effect in pain and psychiatric disorders.

Authors:  R D Holmes; A K Tiwari; J L Kennedy
Journal:  Pharmacogenomics J       Date:  2016-03-22       Impact factor: 3.550

8.  Acceptability, Feasibility, and Effectiveness of Internet-Based Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in New York.

Authors:  Sapana R Patel; Michael G Wheaton; Erik Andersson; Christian Rück; Andrew B Schmidt; Christopher N La Lima; Hanga Galfavy; Olivia Pascucci; Robert W Myers; Lisa B Dixon; Helen Blair Simpson
Journal:  Behav Ther       Date:  2017-09-15

Review 9.  Drug treatment of obsessive-compulsive disorder.

Authors:  Michael Kellner
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

10.  Benzodiazepines versus placebo for panic disorder in adults.

Authors:  Johanna Breilmann; Francesca Girlanda; Giuseppe Guaiana; Corrado Barbui; Andrea Cipriani; Mariasole Castellazzi; Irene Bighelli; Simon Jc Davies; Toshi A Furukawa; Markus Koesters
Journal:  Cochrane Database Syst Rev       Date:  2019-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.